Organic compounds -- part of the class 532-570 series – Organic compounds – Carboxylic acids and salts thereof
Reexamination Certificate
2003-07-18
2008-09-02
Eyler, Yvonne (Department: 1621)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carboxylic acids and salts thereof
Reexamination Certificate
active
07420084
ABSTRACT:
Provides are crystalline forms of nateglinide, labeled Forms A, C, D, F, G, I, J, K, L, M, N, 0, P, Q, T, U, V, Y, α, β, γ, δ, ε, σ, θ and Ω, processes for their preparation and processes for preparation of other crystalline forms of nateglinide. Also provided are their pharmaceutical formulations and methods of administration.
REFERENCES:
patent: 4816484 (1989-03-01), Toyoshima et al.
patent: RE34878 (1995-03-01), Toyoshima et al.
patent: 5463116 (1995-10-01), Sumikawa et al.
patent: 5488150 (1996-01-01), Sumikawa et al.
patent: 6548529 (2003-04-01), Robl et al.
patent: 6555519 (2003-04-01), Washburn
patent: 2001/0044584 (2001-11-01), Kensey
patent: 2002/0032149 (2002-03-01), Kensey
patent: 2002/0061835 (2002-05-01), Kensey
patent: 2003/0069221 (2003-04-01), Kosoglou et al.
patent: 2003/0078517 (2003-04-01), Kensey
patent: 2005/0014836 (2005-01-01), Frenkel et al.
patent: 2005/0090552 (2005-04-01), Yahalomi et al.
patent: 200200360 (2002-07-01), None
patent: WO 01/21159 (2001-03-01), None
patent: WO 02/32854 (2002-04-01), None
patent: WO 02/34254 (2002-05-01), None
patent: WO 02/34285 (2002-05-01), None
patent: WO 02/34713 (2002-05-01), None
patent: WO 02/40010 (2002-05-01), None
patent: WO 03/022251 (2003-03-01), None
patent: WO 03/076393 (2003-09-01), None
patent: WO 03/087038 (2003-10-01), None
patent: WO 03/087039 (2003-10-01), None
patent: WO 03/093222 (2003-11-01), None
Terence L. Threlfall, “Analysis of Organic Polymorphs A Review,” Analyst, vol. 120, Oct. 1995, pp. 2435-2460.
U.S. Appl. No. 10/614,266, filed Jul. 3, 2003, Yahalomi et al.
Hiroko Takesada et al., “Structure Determination of Metabolites Isolated from Urine and Bile after Administration of AY4166, a NovelD-Phenylalanine-Derivative Hypoglycemic Agent,” Bioorganic & Medicinal Chemistry, vol. 4, No. 10, 1996, pp. 1771-1781.
Hisashi Shinkai et al., “N-(Cyclohexylcartonyl)-D-phenylalanines and Related Compounds. A New Class of Oral Hypoglycemic Agents. 2,” J. Med. Chem., vol. 32, 1989, pp. 1436-1441.
Xue-yan Zhu et al., “Study on Synthesis of Nateglinide,” Hecheng Huaxue, vol. 9, No. 6, 2001, pp. 537-540.
Li Gang et al., “A New Crystal Form of Nateglinide,” Acta Pharmaceutica Sinica, vol. 36, No. 7, 2001, pp. 532-534.
Li Gang et al., “Found a New Crystal Structure in Nateglinide by X-ray Powder Diffraction,” Chinese Journal of Pharmaceutical Analysis, vol. 21, No. 5, 2001, pp. 342-344.
A nateglinide having the enclosed XRD (see fig. 17) was purchased before Jul. 3, 2002 in a foreign country from a supplier in another foreign country.
Dolitzky Ben-Zion
Gome Boaz
Gozlan Yigael
Shapiro Evgeny
Wizel Shlomit
Eyler Yvonne
Kenyon & Kenyon LLP
Teva Pharmaceutical Industries Ltd.
Valenrod Yevgeny
LandOfFree
Polymorphic forms of nateglinide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphic forms of nateglinide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphic forms of nateglinide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3966500